Switzerland's second-largest bank Credit Suisse Group (CSR: chart) said net income in 1Q jumped to 1.91 billion Swiss francs, up versus SFr 1.86 billion in the year-earlier quarter and fueled by profit gains in private and corporate banking units. Net income from institutional securities division slid 13% as revenue declined.

The Company’s private-banking division reported an 11% jump in earnings to 685 million francs attributable to recovered client activity.

Overall revenue advanced 1.5% to 17.06 billion francs versus 16.81 billion francs.

Time Warner (TWX: chart) said 1Q net income advanced to $963 million or 20 cents a share, vs. $961 million, or 20 cents a share, with revenue climbing to $10.48 billion vs. $10.18 billion. Analysts were looking for an EPS of 17 cents on revenue of $10.29 billion. Of the media giant’s key units, AOL revenue slid 2.6% to $2.13 billion, cable revenue advanced 9.9% to $2.25 billion, filmed entertainment revenue climbed 0.9% to $3.01 billion, networks revenue grew 4.2% to $2.29 billion and publishing revenue gained 8.1% to $1.24 billion. Time Warner also backed its full year guidance.

Health insurer Cigna Corp. (CI: chart) reported on Wednesday that 1Q earnings more than quadrupled versus last year fueled by the higher profit in the health-care, disability and life, and international businesses, as well as the $169 million gain on the sale of the company’s retirement benefits business.

Net income advanced to $436 million, or $3.28 per share, versus $68 million, or 48 cents per share, a year earlier.

Adjusted income from operations totaled $297 million, or $2.24 per share, up from $253 million, or $1.79 per share, for the comparable period last year. Total revenue dropped to $4.35 billion vs. $4.72 billion last year. Analysts were looking for the company to post earnings of $1.51 per share on sales of $4.02 billion in the latest quarter.

For fiscal 2005, the company is forecasting adjusted profit of $845 million to $915 million, or $6.40 to $6.90 per share, including $585 million to $645 million for the health-care segment. Analysts are expecting earnings of $1.52 and $6.19 per share for 2Q and full year, respectively.

French oil refiner Total (TOT: chart) on Wednesday reported 1Q net income climbed 53% to 3.2 billion euros, topping the average views for net profit of 2.63 billion euros. Sales for the period advanced 18% to 31.7 billion euros on high oil prices and productivity programs. Oil and gas production for the quarter slid 3%.

British American Tobacco (BTI: chart) reported Wednesday that 1Q pretax profit advanced to 624 million pounds, from 575 million pounds a year earlier. Operating profit dropped 4% to 582 million pounds. Reported volumes dropped by 3% to 159 billion, as global drive brands grew by 2% overall. The company cautioned that 1Q 26% EPS growth to 20.10 pence is not indicative of the outlook for the year as a whole.

EFunds Corp. (EFD: chart) said 1Q net income grew to $13.2 million, or 26 cents a share, versus $9.4 million, or 19 cents a share, with revenue decline 19% to $114 million on the sale of its ATM deployment business. The company sees revenue climbing 8% to 12% for 2005, with net income advance of 17% to 22%.

Wireless broadband system maker Alvarion Ltd. (ALVR: chart) said 1Q net income slid to $356,000, or 1 cent a share, vs. $1.4 million, or 3 cents a share, while sales climbed 28% to $57.2 million. Alvarion expects $53 million to $58 million in 2Q sales, with EPS between 0 cents and 3 cents a share.

DPL Inc. (DPL: chart) said 1Q climbed to $73.7 million, or 58 cents a share, versus $49.7 million, or 41 cents a share, fueled by the sale of the company’s private equity funds, while revenue remained steady at $307 million vs. $302 million. The company backed its earnings guidance of 95 cents to $1.05 earnings per share from continuing operations in 2005.

Zebra Technologies Corp. (ZBRA: chart) said 1Q earnings eased to $27.1 million, or 37 cents a share, versus $27.9 million, or 39 cents a share, with sales jump of 10.7% to $171 million mainly due to an order slowdown, including some order deferrals, and distribution capacity constraints in Europe at the end of the quarter. The company’s board has authorized a buyback of up to 1.7 million shares, or 2.5% of total shares outstanding. The company sees sales between $177 million and $187 million and an EPS between 43 cents and 48 cents in 2Q.